These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3494310

  • 1. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
    Lämmle B, Berrettini M, Griffin JH.
    Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
    [Abstract] [Full Text] [Related]

  • 2. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B, Berrettini M, Griffin JH.
    Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135
    [Abstract] [Full Text] [Related]

  • 3. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA, Furlan M, Stricker H, Lämmle B.
    Thromb Haemost; 1992 Feb 03; 67(2):219-25. PubMed ID: 1621242
    [Abstract] [Full Text] [Related]

  • 4. Functional characterization of a variant prekallikrein (PK Zürich).
    Wuillemin WA, Furlan M, von Felten A, Lämmle B.
    Thromb Haemost; 1993 Sep 01; 70(3):427-32. PubMed ID: 8259543
    [Abstract] [Full Text] [Related]

  • 5. Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI.
    Lämmle B, Zuraw BL, Heeb MJ, Schwarz HP, Berrettini M, Curd JG, Griffin JH.
    Thromb Haemost; 1988 Apr 08; 59(2):151-61. PubMed ID: 3388291
    [Abstract] [Full Text] [Related]

  • 6. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F, Ratnoff OD.
    J Lab Clin Med; 1983 Oct 08; 102(4):487-99. PubMed ID: 6604770
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency].
    Iijima K, Nakamura K.
    Rinsho Ketsueki; 1989 Oct 08; 30(10):1702-7. PubMed ID: 2593236
    [Abstract] [Full Text] [Related]

  • 9. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA, Cassello A, De La Cadena RA, Kaufman N, Colman RW.
    Thromb Haemost; 1991 Nov 01; 66(5):540-7. PubMed ID: 1725067
    [Abstract] [Full Text] [Related]

  • 10. Structural and functional characterization of factor XII.
    Tans G, Rosing J.
    Semin Thromb Hemost; 1987 Jan 01; 13(1):1-14. PubMed ID: 3551074
    [Abstract] [Full Text] [Related]

  • 11. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM, Tankersley DL, Mason BL.
    J Lab Clin Med; 1983 Feb 01; 101(2):226-41. PubMed ID: 6549773
    [Abstract] [Full Text] [Related]

  • 12. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T, McIntyre JA.
    J Autoimmun; 2001 Nov 01; 17(3):207-14. PubMed ID: 11712858
    [Abstract] [Full Text] [Related]

  • 13. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D, Silver LD, Hahn S, Colman RW.
    Blood; 1987 Oct 01; 70(4):1053-62. PubMed ID: 2443201
    [Abstract] [Full Text] [Related]

  • 14. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J, Klessen C, Markwardt F.
    Z Med Lab Diagn; 1982 Oct 01; 23(5):306-11. PubMed ID: 6924817
    [No Abstract] [Full Text] [Related]

  • 15. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies.
    Berrettini M, Lämmle B, White T, Heeb MJ, Schwarz HP, Zuraw B, Curd J, Griffin JH.
    Blood; 1986 Aug 01; 68(2):455-62. PubMed ID: 3730610
    [Abstract] [Full Text] [Related]

  • 16. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S, Kaplan AP.
    Blood; 1988 May 01; 71(5):1334-40. PubMed ID: 2451949
    [Abstract] [Full Text] [Related]

  • 17. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA.
    Thromb Haemost; 1999 Sep 01; 82(3):1033-40. PubMed ID: 10494760
    [Abstract] [Full Text] [Related]

  • 18. Immunoblotting of plasma in a pregnant patient with hereditary angioedema.
    Chhibber G, Cohen A, Lane S, Farber A, Meloni FJ, Schmaier AH.
    J Lab Clin Med; 1990 Jan 01; 115(1):112-21. PubMed ID: 1688910
    [Abstract] [Full Text] [Related]

  • 19. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E, Dragosics B, Kopsa H, Mannhalter C, Rainer H.
    Thromb Res; 1983 Jul 15; 31(2):351-64. PubMed ID: 6356459
    [Abstract] [Full Text] [Related]

  • 20. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K, Arakawa Y, Sugahara Y, Matsushita M, Moriguchi Y, Shimohiro H, Nakagawa M.
    Thromb Haemost; 2011 Mar 15; 105(3):473-8. PubMed ID: 21264442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.